HOME >> BIOLOGY >> NEWS
Muscle loss from space travel, prolonged inactivity linked to two genes

(Boston) -- In research that could benefit astronauts posted to the International Space Station as well as individuals whose universe is defined by their sick bed, Boston University Sargent College researchers Susan Kandarian and R. Bridge Hunter have found that disrupting either one of two genes, nfb1 and bcl3, can block the biological process of muscle wasting known as atrophy.

Their findings will inform efforts to identify therapeutics that could inhibit muscle atrophy caused by a chronic reduction in muscle use. Such treatments could end the muscle loss, weakness, and fatigue that can plague space travelers, sedentary or bed-ridden individuals, or anyone whose muscles undergo long periods of disuse.

"By understanding the genes necessary for muscle atrophy," says Kandarian, lead researcher and professor of health sciences at BU Sargent College of Health and Rehabilitation Sciences, "we can begin to study the protein products required for atrophy. Our ongoing research shows that the process of atrophy might be partially moderated by something as straightforward as aspirin or other non-steroidal anti-inflammatory drugs [NSAIDs]."

It is well known that prolonged muscle disuse causes muscles to lose protein in two ways: by decreasing the amount of protein synthesized and by increasing the rate at which muscle protein is degraded. The intracellular signals that drive muscle protein to these extremes, however, are not well known.

When designing her study, Kandarian chose to investigate the role of nfb1 and bcl3, two gene members from a family of transcription factors -- genes that produce proteins that regulate the activities of other genes. Her previous research had shown these transcriptional regulators were implicated in the process of muscle atrophy.

By studying strains of mice bred to be without the nfb1 gene or without the bcl3 gene, so-called knockout mice
'"/>

Contact: Ann Marie Menting
amenting@bu.edu
617-358-1240
Boston University
16-Nov-2004


Page: 1 2 3

Related biology news :

1. Muscle weakness: New mutation identified
2. Muscle and bone from an ink-jet printer
3. Muscle of obese programmed to amass fat, genetic study finds
4. Muscle repair: Making a good system better, faster; implications for aging, disease
5. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
6. Muscle-building hand-grips aid systolic blood pressure, carotid AD, endothelial function
7. Envisat captures first image of Sargassum from space
8. Counting heads or measuring space?
9. Prototype space probe prepares to explore Earths deepest sinkhole
10. West Antarcticas subglacial plumbing system mapped from space
11. Walking tall: UH student working on space suit redesign for NASA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... MANSFIELD, Mass. (PRWEB) , ... June 24, 2020 ... ... provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug ... trials for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
(Date:6/23/2020)... Texas (PRWEB) , ... June 23, 2020 , ... ... analytical instrumentation, is pleased to announce the next event in a series of ... scattering. , The TOPIQ series of webinars was developed in response to social ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... ... the early detection and prevention of high-burden diseases, and Centric Consulting, a business ... healthcare organizations to utilize existing data in order to identify and prioritize patients ...
(Date:7/10/2020)... Mass. (PRWEB) , ... July 09, 2020 , ... ... approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., ... team and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. ...
(Date:7/1/2020)... ... June 30, 2020 , ... Flagship ... of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight provides ... “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists in ...
(Date:6/23/2020)... BOSTON (PRWEB) , ... June 23, 2020 , ... ... to facilitate access to unique lab-made bioresearch materials, today announced the availability of ... Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry ...
Breaking Biology Technology:
Cached News: